Sana Kliniken Leipziger Land GmbH
- Address
- Rudolf-Virchow-Strasse 2, 04552 Borna, Germany
Sana Kliniken Leipziger Land GmbH - Colorectal Cancer Research
Sana Kliniken Leipziger Land GmbH is actively engaged in advanced clinical research focused on optimizing treatment strategies for colorectal malignancies. The center participates in innovative multicenter trials investigating novel therapeutic approaches and precision medicine strategies for patients with colon cancer across various disease stages.
- Preoperative systemic therapy strategies for advanced colon cancer (T3-4 and/or node-positive disease)
- Circulating tumor DNA (ctDNA)-guided treatment decisions in stage II colorectal cancer
- Adjuvant therapy optimization based on molecular biomarkers and disease staging
The research center's portfolio emphasizes both surgical timing optimization and precision oncology approaches. Through participation in Phase III trials such as PROTECTOR/FIRE-10 and CIRCULATE, the institution evaluates critical questions including the role of preoperative chemotherapy versus traditional surgery-first approaches, and the utilization of liquid biopsy technologies to personalize adjuvant treatment decisions in early-stage disease. This work positions the center at the forefront of evidence-based colorectal cancer management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sana Kliniken Leipziger Land GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection | Technische Universitat Dresden | Phase III | Not Recruiting | Dec 2019 | Jan 2026 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 2 | Unknown | 2019-12-04 | 2025-04-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.